JEOL Past Earnings Performance

Past criteria checks 2/6

JEOL has been growing earnings at an average annual rate of 29.6%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 9.4% per year. JEOL's return on equity is 13.3%, and it has net margins of 9.1%.

Key information

29.6%

Earnings growth rate

28.1%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate9.4%
Return on equity13.3%
Net Margin9.1%
Next Earnings Update14 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How JEOL makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:JEL Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23161,87114,71038,75011,259
30 Sep 23166,66418,11738,15711,140
30 Jun 23162,50416,33937,47010,841
31 Mar 23162,68917,83036,44110,391
31 Dec 22155,28618,21335,2789,127
30 Sep 22149,78315,84233,9828,901
30 Jun 22143,47014,73032,5288,738
31 Mar 22138,40812,27831,2358,516
31 Dec 21126,0278,77930,3348,476
30 Sep 21114,4195,47829,5038,259
30 Jun 21113,2854,39328,8678,023
31 Mar 21110,4393,74528,2958,064
31 Dec 20112,6914,41528,0067,942
30 Sep 20115,5196,06228,3087,975
30 Jun 20119,4497,05228,5637,987
31 Mar 20117,2435,35929,1167,756
31 Dec 19117,7846,49228,9237,594
30 Sep 19115,6795,78828,5017,497
30 Jun 19110,0735,09428,2347,349
31 Mar 19111,2895,94027,8447,184
31 Dec 18110,0396,32327,6407,139
30 Sep 18110,5936,64427,4336,754
30 Jun 18108,7275,92527,0886,385
31 Mar 18104,5704,53226,7816,044
31 Dec 17101,8173,71026,1365,187
30 Sep 1795,9612,43125,7685,183
30 Jun 1796,42669525,6015,606
31 Mar 1799,69859525,8336,129
31 Dec 16101,484-30625,7806,698
30 Sep 16105,28922326,4527,050
30 Jun 16108,2591,97726,7427,058
31 Mar 16107,3734,08926,4646,479
31 Dec 15107,5405,84426,7316,142
30 Sep 15103,2015,53625,9975,664
30 Jun 1597,5974,56825,7165,290
31 Mar 1595,3791,79525,3225,515
31 Dec 1499,1113,72924,5865,338
30 Sep 1499,5923,61123,8935,185
30 Jun 14100,7874,23522,8554,747
31 Mar 1499,3313,82222,1814,514
31 Dec 1386,9412,54921,5244,281
30 Sep 1383,1204020,6994,321
30 Jun 1379,466-27220,0894,458

Quality Earnings: JEL has high quality earnings.

Growing Profit Margin: JEL's current net profit margins (9.1%) are lower than last year (11.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: JEL's earnings have grown significantly by 29.6% per year over the past 5 years.

Accelerating Growth: JEL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: JEL had negative earnings growth (-19.2%) over the past year, making it difficult to compare to the Medical Equipment industry average (-9.8%).


Return on Equity

High ROE: JEL's Return on Equity (13.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.